Karyopharm secures forbearance through Oct. 15; issues $20M 0% converts
Karyopharm Therapeutics secured a short-term forbearance after missing a $15.8 million term-loan payment, pausing specified enforcement actions through an earlier date of Oct. 15, 2026 or certain triggers. The company also agreed to issue $20 million 0% convertible preferred.